ID   KCC2B_RAT               Reviewed;         542 AA.
AC   P08413;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   02-OCT-2024, entry version 196.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type II subunit beta;
DE            Short=CaM kinase II subunit beta;
DE            Short=CaMK-II subunit beta;
DE            EC=2.7.11.17 {ECO:0000269|PubMed:11972023};
GN   Name=Camk2b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=3470758; DOI=10.1073/pnas.84.7.1794;
RA   Bennett M.K., Kennedy M.B.;
RT   "Deduced primary structure of the beta subunit of brain type II
RT   Ca2+/calmodulin-dependent protein kinase determined by molecular cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:1794-1798(1987).
RN   [2]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9768845; DOI=10.1016/s0896-6273(00)80569-3;
RA   Shen K., Teruel M.N., Subramanian K., Meyer T.;
RT   "CaMKIIbeta functions as an F-actin targeting module that localizes
RT   CaMKIIalpha/beta heterooligomers to dendritic spines.";
RL   Neuron 21:593-606(1998).
RN   [3]
RP   INTERACTION WITH CAMK2N2.
RX   PubMed=9724800; DOI=10.1073/pnas.95.18.10890;
RA   Chang B.H., Mukherji S., Soderling T.R.;
RT   "Characterization of a calmodulin kinase II inhibitor protein in brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:10890-10895(1998).
RN   [4]
RP   INTERACTION WITH CAMK2N1.
RX   PubMed=11182241; DOI=10.1016/s0306-4522(00)00520-0;
RA   Chang B.H., Mukherji S., Soderling T.R.;
RT   "Calcium/calmodulin-dependent protein kinase II inhibitor protein:
RT   localization of isoforms in rat brain.";
RL   Neuroscience 102:767-777(2001).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11972023; DOI=10.1073/pnas.052159099;
RA   Nair J.S., DaFonseca C.J., Tjernberg A., Sun W., Darnell J.E. Jr.,
RA   Chait B.T., Zhang J.J.;
RT   "Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in
RT   response to IFN-gamma.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:5971-5976(2002).
RN   [6]
RP   FUNCTION IN SYNAPSE FORMATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   LYS-43; THR-287 AND ALA-303.
RX   PubMed=12873385; DOI=10.1016/s0896-6273(03)00428-8;
RA   Fink C.C., Bayer K.U., Myers J.W., Ferrell J.E. Jr., Schulman H., Meyer T.;
RT   "Selective regulation of neurite extension and synapse formation by the
RT   beta but not the alpha isoform of CaMKII.";
RL   Neuron 39:283-297(2003).
RN   [7]
RP   INTERACTION WITH SYNGAP1 AND MPDZ, AND FUNCTION.
RX   PubMed=15312654; DOI=10.1016/j.neuron.2004.08.003;
RA   Krapivinsky G., Medina I., Krapivinsky L., Gapon S., Clapham D.E.;
RT   "SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity
RT   and NMDA receptor-dependent synaptic AMPA receptor potentiation.";
RL   Neuron 43:563-574(2004).
RN   [8]
RP   INDUCTION BY COCAINE.
RX   PubMed=16891908; DOI=10.1097/01.fjc.0000211796.45281.46;
RA   Henning R.J., Cuevas J.;
RT   "Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte
RT   hypertrophy.";
RL   J. Cardiovasc. Pharmacol. 48:802-813(2006).
RN   [9]
RP   FUNCTION, INDUCTION, AND PHOSPHORYLATION AT THR-287.
RX   PubMed=17272343; DOI=10.1113/jphysiol.2006.127464;
RA   Rose A.J., Alsted T.J., Kobberoe J.B., Richter E.A.;
RT   "Regulation and function of Ca2+-calmodulin-dependent protein kinase II of
RT   fast-twitch rat skeletal muscle.";
RL   J. Physiol. (Lond.) 580:993-1005(2007).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH ARC.
RX   PubMed=22579289; DOI=10.1016/j.cell.2012.02.062;
RA   Okuno H., Akashi K., Ishii Y., Yagishita-Kyo N., Suzuki K., Nonaka M.,
RA   Kawashima T., Fujii H., Takemoto-Kimura S., Abe M., Natsume R.,
RA   Chowdhury S., Sakimura K., Worley P.F., Bito H.;
RT   "Inverse synaptic tagging of inactive synapses via dynamic interaction of
RT   Arc/Arg3.1 with CaMKIIbeta.";
RL   Cell 149:886-898(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; SER-394; SER-397 AND
RP   THR-401, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that functions
CC       autonomously after Ca(2+)/calmodulin-binding and autophosphorylation,
CC       and is involved in dendritic spine and synapse formation, neuronal
CC       plasticity and regulation of sarcoplasmic reticulum Ca(2+) transport in
CC       skeletal muscle (PubMed:12873385, PubMed:15312654). In neurons, plays
CC       an essential structural role in the reorganization of the actin
CC       cytoskeleton during plasticity by binding and bundling actin filaments
CC       in a kinase-independent manner. This structural function is required
CC       for correct targeting of CaMK2A, which acts downstream of NMDAR to
CC       promote dendritic spine and synapse formation and maintain synaptic
CC       plasticity which enables long-term potentiation (LTP) and hippocampus-
CC       dependent learning. In developing hippocampal neurons, promotes
CC       arborization of the dendritic tree and in mature neurons, promotes
CC       dendritic remodeling. Also regulates the migration of developing
CC       neurons. Participates in the modulation of skeletal muscle function in
CC       response to exercise (PubMed:17272343). In slow-twitch muscles, is
CC       involved in regulation of sarcoplasmic reticulum (SR) Ca(2+) transport
CC       and in fast-twitch muscle participates in the control of Ca(2+) release
CC       from the SR through phosphorylation of triadin, a ryanodine receptor-
CC       coupling factor, and phospholamban (PLN/PLB), an endogenous inhibitor
CC       of SERCA2A/ATP2A2. In response to interferon-gamma (IFN-gamma)
CC       stimulation, catalyzes phosphorylation of STAT1, stimulating the JAK-
CC       STAT signaling pathway (PubMed:11972023). Phosphorylates reticulophagy
CC       regulator RETREG1 at 'Ser-134' under endoplasmic reticulum stress
CC       conditions which enhances RETREG1 oligomerization and its membrane
CC       scission and reticulophagy activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q13554, ECO:0000269|PubMed:11972023,
CC       ECO:0000269|PubMed:12873385, ECO:0000269|PubMed:15312654,
CC       ECO:0000269|PubMed:17272343}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC         Evidence={ECO:0000269|PubMed:11972023};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17;
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in conformational change that relieves intrasteric
CC       autoinhibition and allows autophosphorylation of Thr-287 which turns
CC       the kinase in a constitutively active form and confers to the kinase a
CC       Ca(2+)-independent activity.
CC   -!- SUBUNIT: CAMK2 is composed of 4 different chains: alpha (CAMK2A), beta
CC       (CAMK2B), gamma (CAMK2G), and delta (CAMK2D). The different isoforms
CC       assemble into homo- or heteromultimeric holoenzymes composed of 12
CC       subunits with two hexameric rings stacked one on top of the other (By
CC       similarity). Interacts with SYNGAP1, CAMK2N2 and MPDZ (PubMed:15312654,
CC       PubMed:9724800). Interacts with FOXO3 (By similarity). Interacts (when
CC       in a kinase inactive state not associated with calmodulin) with ARC;
CC       leading to target ARC to inactive synapses (PubMed:22579289). Interacts
CC       with CAMK2N1; this interaction requires CAMK2B activation by Ca(2+)
CC       (PubMed:11182241). {ECO:0000250|UniProtKB:P28652,
CC       ECO:0000250|UniProtKB:Q13554, ECO:0000269|PubMed:11182241,
CC       ECO:0000269|PubMed:15312654, ECO:0000269|PubMed:22579289,
CC       ECO:0000269|PubMed:9724800}.
CC   -!- INTERACTION:
CC       P08413; Q63053: Arc; NbExp=6; IntAct=EBI-916155, EBI-5275794;
CC       P08413; P60709: ACTB; Xeno; NbExp=4; IntAct=EBI-916155, EBI-353944;
CC       P08413; P62195: PSMC5; Xeno; NbExp=3; IntAct=EBI-916155, EBI-357745;
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}; Cytoplasmic side
CC       {ECO:0000250}. Synapse {ECO:0000269|PubMed:22579289}. Cytoplasm,
CC       cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome. Note=Colocalizes with the cortical actin cytoskeleton by
CC       binding to F-actin in hippocampal cells.
CC   -!- INDUCTION: By cocaine in cardiomyocytes. {ECO:0000269|PubMed:16891908,
CC       ECO:0000269|PubMed:17272343}.
CC   -!- DOMAIN: The CAMK2 protein kinases contain a unique C-terminal subunit
CC       association domain responsible for oligomerization.
CC   -!- PTM: Autophosphorylation of Thr-287 following activation by
CC       Ca(2+)/calmodulin. Phosphorylation of Thr-287 locks the kinase into an
CC       activated state. {ECO:0000269|PubMed:17272343}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M16112; AAA41866.1; -; mRNA.
DR   PIR; A26464; A26464.
DR   RefSeq; NP_001035815.1; NM_001042356.1.
DR   RefSeq; NP_068507.2; NM_021739.2.
DR   PDB; 6HCS; X-ray; 2.00 A; B/D/F/H=291-315.
DR   PDB; 8T17; EM; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=409-542.
DR   PDB; 8T18; EM; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L=409-542.
DR   PDB; 8T6K; EM; 3.00 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N=1-542.
DR   PDB; 8T6Q; EM; 3.50 A; A/B/C/D/F/G/H/I/J/K/L/N=1-542.
DR   PDBsum; 6HCS; -.
DR   PDBsum; 8T17; -.
DR   PDBsum; 8T18; -.
DR   PDBsum; 8T6K; -.
DR   PDBsum; 8T6Q; -.
DR   AlphaFoldDB; P08413; -.
DR   EMDB; EMD-40956; -.
DR   EMDB; EMD-40957; -.
DR   SMR; P08413; -.
DR   BioGRID; 246430; 15.
DR   CORUM; P08413; -.
DR   DIP; DIP-36948N; -.
DR   IntAct; P08413; 8.
DR   MINT; P08413; -.
DR   STRING; 10116.ENSRNOP00000058882; -.
DR   BindingDB; P08413; -.
DR   ChEMBL; CHEMBL2610; -.
DR   iPTMnet; P08413; -.
DR   PhosphoSitePlus; P08413; -.
DR   jPOST; P08413; -.
DR   GeneID; 24245; -.
DR   KEGG; rno:24245; -.
DR   UCSC; RGD:2262; rat.
DR   AGR; RGD:2262; -.
DR   CTD; 816; -.
DR   RGD; 2262; Camk2b.
DR   InParanoid; P08413; -.
DR   OrthoDB; 1121238at2759; -.
DR   PhylomeDB; P08413; -.
DR   BRENDA; 2.7.11.17; 5301.
DR   Reactome; R-RNO-3371571; HSF1-dependent transactivation.
DR   Reactome; R-RNO-399719; Trafficking of AMPA receptors.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-5673000; RAF activation.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-877300; Interferon gamma signaling.
DR   Reactome; R-RNO-936837; Ion transport by P-type ATPases.
DR   PRO; PR:P08413; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005954; C:calcium- and calmodulin-dependent protein kinase complex; ISO:RGD.
DR   GO; GO:0005813; C:centrosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0051233; C:spindle midzone; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0009931; F:calcium-dependent protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043274; F:phospholipase binding; IDA:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0098973; F:structural constituent of postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0060466; P:activation of meiosis involved in egg activation; ISO:RGD.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0048858; P:cell projection morphogenesis; IMP:RGD.
DR   GO; GO:1905375; P:cellular response to homocysteine; IEP:RGD.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0110088; P:hippocampal neuron apoptotic process; IEP:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IMP:MGI.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IMP:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:UniProtKB.
DR   GO; GO:0090129; P:positive regulation of synapse maturation; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:2001222; P:regulation of neuron migration; ISS:UniProtKB.
DR   GO; GO:1903076; P:regulation of protein localization to plasma membrane; IGI:ARUK-UCL.
DR   GO; GO:0090128; P:regulation of synapse maturation; IDA:SynGO.
DR   GO; GO:0032222; P:regulation of synaptic transmission, cholinergic; ISO:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; ISO:RGD.
DR   GO; GO:1990911; P:response to psychosocial stress; IEP:RGD.
DR   CDD; cd14086; STKc_CaMKII; 1.
DR   Gene3D; 3.10.450.50; -; 1.
DR   Gene3D; 6.10.140.620; -; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR013543; Ca/CaM-dep_prot_kinase-assoc.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR032710; NTF2-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347:SF403; CALCIUM_CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II SUBUNIT BETA; 1.
DR   PANTHER; PTHR24347; SERINE/THREONINE-PROTEIN KINASE; 1.
DR   Pfam; PF08332; CaMKII_AD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54427; NTF2-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calmodulin-binding; Cytoplasm; Cytoskeleton;
KW   Differentiation; Kinase; Membrane; Neurogenesis; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Sarcoplasmic reticulum;
KW   Serine/threonine-protein kinase; Synapse; Transferase.
FT   CHAIN           1..542
FT                   /note="Calcium/calmodulin-dependent protein kinase type II
FT                   subunit beta"
FT                   /id="PRO_0000086098"
FT   DOMAIN          14..272
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          283..292
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000250"
FT   REGION          291..301
FT                   /note="Calmodulin-binding"
FT   REGION          349..376
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        350..369
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        136
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         20..28
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         43
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         17
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P28652"
FT   MOD_RES         287
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:17272343"
FT   MOD_RES         306
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         307
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         367
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         371
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P28652"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         397
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         400
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P28652"
FT   MOD_RES         401
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         43
FT                   /note="K->R: Catalytically inactive form."
FT                   /evidence="ECO:0000269|PubMed:12873385"
FT   MUTAGEN         287
FT                   /note="T->D: Constitutively active form."
FT                   /evidence="ECO:0000269|PubMed:12873385"
FT   MUTAGEN         303
FT                   /note="A->R: Blocks calcium/calmodulin binding."
FT                   /evidence="ECO:0000269|PubMed:12873385"
FT   HELIX           296..310
FT                   /evidence="ECO:0007829|PDB:6HCS"
SQ   SEQUENCE   542 AA;  60402 MW;  8A7962A64AE930D0 CRC64;
     MATTVTCTRF TDEYQLYEDI GKGAFSVVRR CVKLCTGHEY AAKIINTKKL SARDHQKLER
     EARICRLLKH SNIVRLHDSI SEEGFHYLVF DLVTGGELFE DIVAREYYSE ADASHCIQQI
     LEAVLHCHQM GVVHRDLKPE NLLLASKCKG AAVKLADFGL AIEVQGDQQA WFGFAGTPGY
     LSPEVLRKEA YGKPVDIWAC GVILYILLVG YPPFWDEDQH KLYQQIKAGA YDFPSPEWDT
     VTPEAKNLIN QMLTINPAKR ITAHEALKHP WVCQRSTVAS MMHRQETVEC LKKFNARRKL
     KGAILTTMLA TRNFSVGRQT TAPATMSTAA SGTTMGLVEQ AKSLLNKKAD GVKPQTNSTK
     NSSAITSPKG SLPPAALEPQ TTVIHNPVDG IKESSDSTNT TIEDEDAKAR KQEIIKTTEQ
     LIEAVNNGDF EAYAKICDPG LTSFEPEALG NLVEGMDFHR FYFENLLAKN SKPIHTTILN
     PHVHVIGEDA ACIAYIRLTQ YIDGQGRPRT SQSEETRVWH RPDGKWQNVH FHCSGAPVAP
     LQ
//
